pillbase.ru

Dacogen

Active substance: decitabine

decitabine

Centralised EU authorisationActive

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 23
  • DECITABINE
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/1
    68001-573
    BluePoint Laboratories
  • DECITABINE
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/20mL
    75834-190
    Nivagen Pharmaceuticals, Inc.
  • Decitabine
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/20mL
    68001-618
    BluePoint Laboratories
  • Decitabine
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/26mL
    55150-376
    Eugia US LLC
  • Decitabine
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/10mL
    31722-304
    Camber Pharmaceuticals, Inc.
All products in this country (23)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a1e5-7778-aec5-2ce49d64b788,01a1208d-4297-71b7-8c53-c31dbe9e075d,01a1208e-17b5-7cf2-b7a2-0a97b4e44cd8,01a1208e-b430-7272-88a5-7b0ee5dc7a20,01a1208e-b795-7f21-ab3e-8abfc8a8243c;count=22 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002221
Registration status
Active
ATC code
L01BC08
Sources
  • product · EMA · EMEA/H/C/002221 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002221 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002221 · Verified 2026-10-09